Beroctocog alfa Completed Phase 4 Trials for Congenital Hematological Disorder / Hemophilia B With Inhibitors / Hemophilia A With Inhibitors Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01561391Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery